25 XP   0   0   10

Rxsight Inc
Buy, Hold or Sell?

Let's analyse Rxsight together

PenkeI guess you are interested in Rxsight Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Rxsight Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Rxsight Inc

I send you an email if I find something interesting about Rxsight Inc.

Quick analysis of Rxsight (30 sec.)










What can you expect buying and holding a share of Rxsight? (30 sec.)

How much money do you get?

How much money do you get?
$0.04
When do you have the money?
1 year
How often do you get paid?
18.8%

What is your share worth?

Current worth
$4.34
Expected worth in 1 year
$6.24
How sure are you?
25.0%

+ What do you gain per year?

Total Gains per Share
$1.94
Return On Investment
3.8%

For what price can you sell your share?

Current Price per Share
$50.67
Expected price per share
$43.55 - $58.21
How sure are you?
50%

1. Valuation of Rxsight (5 min.)




Live pricePrice per Share (EOD)

$50.67

Intrinsic Value Per Share

$-13.99 - $-16.24

Total Value Per Share

$-9.65 - $-11.90

2. Growth of Rxsight (5 min.)




Is Rxsight growing?

Current yearPrevious yearGrowGrow %
How rich?$160.3m$104.7m$51.2m32.9%

How much money is Rxsight making?

Current yearPrevious yearGrowGrow %
Making money-$12.5m-$17.1m$4.5m36.5%
Net Profit Margin-55.9%-147.4%--

How much money comes from the company's main activities?

3. Financial Health of Rxsight (5 min.)




4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  


Richest
#120 / 340

Most Revenue
#144 / 340

Most Profit
#278 / 340

Most Efficient
#218 / 340

What can you expect buying and holding a share of Rxsight? (5 min.)

Welcome investor! Rxsight's management wants to use your money to grow the business. In return you get a share of Rxsight.

What can you expect buying and holding a share of Rxsight?

First you should know what it really means to hold a share of Rxsight. And how you can make/lose money.

Speculation

The Price per Share of Rxsight is $50.67. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Rxsight.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Rxsight, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $4.34. Based on the TTM, the Book Value Change Per Share is $0.48 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.33 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.01 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Rxsight.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.25-0.5%-0.33-0.6%-0.45-0.9%-0.29-0.6%-0.29-0.6%
Usd Book Value Change Per Share-0.03-0.1%0.480.9%-0.33-0.6%0.270.5%0.270.5%
Usd Dividend Per Share0.000.0%0.010.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.03-0.1%0.491.0%-0.32-0.6%0.270.5%0.270.5%
Usd Price Per Share40.32-28.42-12.78-11.80-11.80-
Price to Earnings Ratio-40.63--23.09--7.10--8.54--8.54-
Price-to-Total Gains Ratio-1,335.13--261.15--44.89--125.61--125.61-
Price to Book Ratio9.30-6.68-4.57-3.20-3.20-
Price-to-Total Gains Ratio-1,335.13--261.15--44.89--125.61--125.61-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share50.67
Number of shares19
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.010.00
Usd Book Value Change Per Share0.480.27
Usd Total Gains Per Share0.490.27
Gains per Quarter (19 shares)9.235.20
Gains per Year (19 shares)36.9220.81
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
11362702111
21726404132
3210910116253
4314513818274
54181175110395
642172121124116
752532492144137
862902862165158
973263232185179
1073623602206200

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%2.014.00.012.5%2.014.00.012.5%2.014.00.012.5%
Book Value Change Per Share3.01.00.075.0%4.08.00.033.3%4.09.03.025.0%4.09.03.025.0%4.09.03.025.0%
Dividend per Share2.00.02.050.0%3.00.09.025.0%3.00.013.018.8%3.00.013.018.8%3.00.013.018.8%
Total Gains per Share3.01.00.075.0%4.08.00.033.3%4.09.03.025.0%4.09.03.025.0%4.09.03.025.0%

Fundamentals of Rxsight

About Rxsight Inc

RxSight, Inc., a commercial-stage medical device company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight Light Adjustable Lens, a special photosensitive material that changes shape and power. RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. It primarily serves cataract doctors. The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California.

Fundamental data was last updated by Penke on 2024-03-22 03:12:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Rxsight Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Rxsight earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Rxsight to the Medical Devices industry mean.
  • A Net Profit Margin of -32.1% means that $-0.32 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Rxsight Inc:

  • The MRQ is -32.1%. The company is making a huge loss. -2
  • The TTM is -55.9%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-32.1%TTM-55.9%+23.8%
TTM-55.9%YOY-147.4%+91.4%
TTM-55.9%5Y-91.7%+35.7%
5Y-91.7%10Y-91.7%0.0%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-32.1%-11.0%-21.1%
TTM-55.9%-20.2%-35.7%
YOY-147.4%-14.0%-133.4%
5Y-91.7%-19.5%-72.2%
10Y-91.7%-23.8%-67.9%
1.1.2. Return on Assets

Shows how efficient Rxsight is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Rxsight to the Medical Devices industry mean.
  • -5.0% Return on Assets means that Rxsight generated $-0.05 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Rxsight Inc:

  • The MRQ is -5.0%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -6.6%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-5.0%TTM-6.6%+1.5%
TTM-6.6%YOY-10.6%+4.0%
TTM-6.6%5Y-4.9%-1.7%
5Y-4.9%10Y-4.9%0.0%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-5.0%-3.1%-1.9%
TTM-6.6%-4.2%-2.4%
YOY-10.6%-4.0%-6.6%
5Y-4.9%-3.8%-1.1%
10Y-4.9%-4.1%-0.8%
1.1.3. Return on Equity

Shows how efficient Rxsight is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Rxsight to the Medical Devices industry mean.
  • -5.7% Return on Equity means Rxsight generated $-0.06 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Rxsight Inc:

  • The MRQ is -5.7%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -8.1%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-5.7%TTM-8.1%+2.4%
TTM-8.1%YOY-16.5%+8.4%
TTM-8.1%5Y-7.4%-0.7%
5Y-7.4%10Y-7.4%0.0%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-5.7%-3.5%-2.2%
TTM-8.1%-4.4%-3.7%
YOY-16.5%-4.7%-11.8%
5Y-7.4%-5.7%-1.7%
10Y-7.4%-6.2%-1.2%

1.2. Operating Efficiency of Rxsight Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Rxsight is operating .

  • Measures how much profit Rxsight makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Rxsight to the Medical Devices industry mean.
  • An Operating Margin of -38.0% means the company generated $-0.38  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Rxsight Inc:

  • The MRQ is -38.0%. The company is operating very inefficient. -2
  • The TTM is -53.6%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-38.0%TTM-53.6%+15.6%
TTM-53.6%YOY-136.0%+82.5%
TTM-53.6%5Y-174.3%+120.7%
5Y-174.3%10Y-174.3%0.0%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-38.0%-24.5%-13.5%
TTM-53.6%-14.9%-38.7%
YOY-136.0%-11.5%-124.5%
5Y-174.3%-17.1%-157.2%
10Y-174.3%-20.6%-153.7%
1.2.2. Operating Ratio

Measures how efficient Rxsight is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 1.38 means that the operating costs are $1.38 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Rxsight Inc:

  • The MRQ is 1.380. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.548. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.380TTM1.548-0.168
TTM1.548YOY2.360-0.812
TTM1.5485Y2.750-1.202
5Y2.75010Y2.7500.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3801.454-0.074
TTM1.5481.452+0.096
YOY2.3601.434+0.926
5Y2.7501.432+1.318
10Y2.7501.366+1.384

1.3. Liquidity of Rxsight Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Rxsight is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 8.06 means the company has $8.06 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Rxsight Inc:

  • The MRQ is 8.057. The company is very able to pay all its short-term debts. +2
  • The TTM is 10.108. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ8.057TTM10.108-2.051
TTM10.108YOY10.741-0.633
TTM10.1085Y9.050+1.058
5Y9.05010Y9.0500.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ8.0572.789+5.268
TTM10.1082.793+7.315
YOY10.7413.586+7.155
5Y9.0503.492+5.558
10Y9.0503.450+5.600
1.3.2. Quick Ratio

Measures if Rxsight is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Rxsight to the Medical Devices industry mean.
  • A Quick Ratio of 12.68 means the company can pay off $12.68 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Rxsight Inc:

  • The MRQ is 12.675. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 16.431. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ12.675TTM16.431-3.756
TTM16.431YOY17.438-1.006
TTM16.4315Y14.150+2.282
5Y14.15010Y14.1500.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ12.6751.587+11.088
TTM16.4311.633+14.798
YOY17.4382.155+15.283
5Y14.1502.300+11.850
10Y14.1502.255+11.895

1.4. Solvency of Rxsight Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Rxsight assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Rxsight to Medical Devices industry mean.
  • A Debt to Asset Ratio of 0.12 means that Rxsight assets are financed with 12.2% credit (debt) and the remaining percentage (100% - 12.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Rxsight Inc:

  • The MRQ is 0.122. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.178. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.122TTM0.178-0.057
TTM0.178YOY0.357-0.179
TTM0.1785Y0.942-0.764
5Y0.94210Y0.9420.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1220.400-0.278
TTM0.1780.386-0.208
YOY0.3570.330+0.027
5Y0.9420.440+0.502
10Y0.9420.460+0.482
1.4.2. Debt to Equity Ratio

Measures if Rxsight is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Rxsight to the Medical Devices industry mean.
  • A Debt to Equity ratio of 13.8% means that company has $0.14 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Rxsight Inc:

  • The MRQ is 0.138. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.226. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.138TTM0.226-0.087
TTM0.226YOY0.562-0.336
TTM0.2265Y0.243-0.018
5Y0.24310Y0.2430.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1380.570-0.432
TTM0.2260.569-0.343
YOY0.5620.479+0.083
5Y0.2430.626-0.383
10Y0.2430.692-0.449

2. Market Valuation of Rxsight Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Rxsight generates.

  • Above 15 is considered overpriced but always compare Rxsight to the Medical Devices industry mean.
  • A PE ratio of -40.63 means the investor is paying $-40.63 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Rxsight Inc:

  • The EOD is -51.056. Based on the earnings, the company is expensive. -2
  • The MRQ is -40.627. Based on the earnings, the company is expensive. -2
  • The TTM is -23.092. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-51.056MRQ-40.627-10.429
MRQ-40.627TTM-23.092-17.536
TTM-23.092YOY-7.098-15.994
TTM-23.0925Y-8.538-14.553
5Y-8.53810Y-8.5380.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-51.056-1.038-50.018
MRQ-40.627-1.216-39.411
TTM-23.092-1.757-21.335
YOY-7.098-2.588-4.510
5Y-8.538-1.553-6.985
10Y-8.538-1.463-7.075
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Rxsight Inc:

  • The EOD is -40.814. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -32.477. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -24.775. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-40.814MRQ-32.477-8.337
MRQ-32.477TTM-24.775-7.702
TTM-24.775YOY-7.730-17.045
TTM-24.7755Y-9.364-15.411
5Y-9.36410Y-9.3640.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-40.814-1.228-39.586
MRQ-32.477-1.746-30.731
TTM-24.775-2.961-21.814
YOY-7.730-6.157-1.573
5Y-9.364-4.928-4.436
10Y-9.364-5.626-3.738
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Rxsight is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of 9.30 means the investor is paying $9.30 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Rxsight Inc:

  • The EOD is 11.687. Based on the equity, the company is expensive. -2
  • The MRQ is 9.300. Based on the equity, the company is overpriced. -1
  • The TTM is 6.680. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD11.687MRQ9.300+2.387
MRQ9.300TTM6.680+2.620
TTM6.680YOY4.573+2.107
TTM6.6805Y3.195+3.485
5Y3.19510Y3.1950.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD11.6872.038+9.649
MRQ9.3002.321+6.979
TTM6.6802.444+4.236
YOY4.5733.047+1.526
5Y3.1953.918-0.723
10Y3.1954.245-1.050
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Rxsight Inc.

3.1. Institutions holding Rxsight Inc

Institutions are holding 90.251% of the shares of Rxsight Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31RA Capital Management, LLC9.20392.1439340428535148911.5137
2023-12-31Artisan Partners Limited Partnership6.4770.14872395672-42093-1.7267
2023-12-31BlackRock Inc5.6140.0021207647022338112.0545
2023-12-31Lord, Abbett & Co LLC5.3450.2863197700034868021.4135
2023-12-31Vanguard Group Inc4.01220.00131484010500573.4908
2023-12-31FMR Inc3.20780.003711864771185612137064.9711
2023-12-31Morgan Stanley - Brokerage Accounts2.90110.00381073062-138342-11.42
2023-12-31T. Rowe Price Investment Management,Inc.2.59030.025195810541741777.2011
2023-12-31Deutsche Bank AG1.90980.01457063946926305032.1854
2023-12-31State Street Corporation1.90330.001470396760.0009
2023-12-31Nuveen Asset Management, LLC1.88090.00969570526422861.238
2023-12-31Next Century Growth Investors LLC1.77632.5766657021-90806-12.1426
2023-09-30Point72 Asset Management, L.P.1.77340.05346559458350214.587
2023-12-31JPMorgan Chase & Co1.61280.0023596540449758.1541
2023-12-31Geode Capital Management, LLC1.510.0024558507403687.791
2023-12-31Bank of America Corp1.4560.0022538550-94644-14.9471
2023-12-31Driehaus Capital Management LLC1.43080.2571529220-64738-10.8994
2023-12-31Parkman Healthcare Partners LLC1.3872.913751303213170134.5372
2023-12-31Atika Capital Management LLC1.20042.3973444000-65352-12.8304
2023-09-30VOLORIDGE INVESTMENT MANAGEMENT, LLC0.96420.049135664317448895.7909
Total 58.156210.893921510605+3512559+16.3%

3.2. Funds holding Rxsight Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Artisan International Small-Mid Investor4.06761.3528150451958140.3879
2023-12-31Artisan Non-U.S. Small-Mid Growth Comp4.06761.3515150451958140.3879
2024-01-31Lord Abbett Developing Growth A2.63261.9164973748-12368-1.2542
2024-01-31Vanguard Total Stock Mkt Idx Inv2.15730.002579793800
2024-02-29iShares Russell 2000 ETF1.86050.0602688157-112-0.0163
2023-12-31Fidelity Small Cap Growth1.58760.4146587200297619102.7757
2023-10-31Old Westbury Small & Mid Cap Strategies1.00540.12163718725519317.4287
2024-01-31Vanguard Institutional Extnd Mkt Idx Tr0.92440.01623419061320.0386
2023-12-31Fidelity Small Cap Index0.76430.0449282695167916.3147
2024-02-29iShares Russell 2000 Growth ETF0.67450.1199249485-290-0.1161
2023-12-31TIAA-CREF Quant Small-Cap Equity Instl0.59670.293722069000
2023-12-31Fidelity Small Cap Growth K60.57370.4075212200106575100.8994
2024-01-31Heptagon Driehaus US Micro Cap Eq C$ Acc0.5721.281821158400
2023-12-31CREF Stock R10.54740.00692024606030042.417
2023-12-31T. Rowe Price US Smlr Cm Eq A USD0.52480.2807194127160619.0197
2023-12-31Timpani Small Cap Growth Equity0.49522.8285183156-42591-18.8667
2024-01-31Calamos Timpani Small Cap Growth I0.47673.1465176306-6850-3.74
2024-01-31State St Russell Sm/Mid Cp® Indx NL Cl C0.45750.020116922600
2024-01-31Strategic Advisers Fidelity US TtlStk0.41610.0072153900127550484.0607
2023-12-31Federated Hermes MDT Small Cap Core IS0.40050.5061148136-25835-14.8502
Total 24.802414.17969173824+603803+6.6%

3.3. Insider Transactions

Insiders are holding 12.985% of the shares of Rxsight Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-03-01Shelley B ThunenSELL1000056.37
2024-02-14Bakker Juliet TammenomsBUY400051.29
2024-02-12Bakker Juliet TammenomsBUY400050.38
2024-02-09Ilya GoldshlegerSELL1036550.74
2024-02-05Shelley B ThunenSELL912547.02
2024-02-01Eric WeinbergSELL1000050
2024-02-01Ilya GoldshlegerSELL712949.29
2024-02-01William J Phd LinkSELL2825049.67
2024-01-26Shelley B ThunenSELL3177247.11
2024-01-22Eric WeinbergSELL1000048
2024-01-22Ilya GoldshlegerSELL500048
2024-01-18Shweta ManiarSELL639945.72
2024-01-08Eric WeinbergSELL1000042
2024-01-08Ilya GoldshlegerSELL1500043.33
2024-01-08Robert Keith WarnerSELL2375042.69
2024-01-08Ronald M Md KurtzSELL6250044.25
2023-12-27Ronald M Md KurtzSELL2250041.09
2023-12-22Eric WeinbergSELL128540
2023-12-22Ilya GoldshlegerSELL500040
2023-12-18Ilya GoldshlegerSELL1093739.02

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Rxsight Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.0300.476-106%-0.327+982%0.271-111%0.271-111%
Book Value Per Share--4.3364.218+3%2.832+53%0.709+512%0.709+512%
Current Ratio--8.05710.108-20%10.741-25%9.050-11%9.050-11%
Debt To Asset Ratio--0.1220.178-32%0.357-66%0.942-87%0.942-87%
Debt To Equity Ratio--0.1380.226-39%0.562-75%0.243-43%0.243-43%
Dividend Per Share---0.010-100%0.002-100%0.003-100%0.003-100%
Eps---0.248-0.329+32%-0.451+82%-0.287+15%-0.287+15%
Free Cash Flow Per Share---0.310-0.324+5%-0.414+33%-0.327+5%-0.327+5%
Free Cash Flow To Equity Per Share---0.1710.102-267%-0.371+117%0.065-364%0.065-364%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---16.237--------
Intrinsic Value_10Y_min---13.988--------
Intrinsic Value_1Y_max---1.439--------
Intrinsic Value_1Y_min---1.413--------
Intrinsic Value_3Y_max---4.467--------
Intrinsic Value_3Y_min---4.262--------
Intrinsic Value_5Y_max---7.668--------
Intrinsic Value_5Y_min---7.105--------
Market Cap1874161692.000+20%1491340032.0001051280061.000+42%472793997.000+215%436314976.500+242%436314976.500+242%
Net Profit Margin---0.321-0.559+74%-1.474+359%-0.917+185%-0.917+185%
Operating Margin---0.380-0.536+41%-1.360+258%-1.743+359%-1.743+359%
Operating Ratio--1.3801.548-11%2.360-42%2.750-50%2.750-50%
Pb Ratio11.687+20%9.3006.680+39%4.573+103%3.195+191%3.195+191%
Pe Ratio-51.056-26%-40.627-23.092-43%-7.098-83%-8.538-79%-8.538-79%
Price Per Share50.670+20%40.32028.423+42%12.783+215%11.796+242%11.796+242%
Price To Free Cash Flow Ratio-40.814-26%-32.477-24.775-24%-7.730-76%-9.364-71%-9.364-71%
Price To Total Gains Ratio-1677.853-26%-1335.130-261.154-80%-44.887-97%-125.605-91%-125.605-91%
Quick Ratio--12.67516.431-23%17.438-27%14.150-10%14.150-10%
Return On Assets---0.050-0.066+31%-0.106+110%-0.049-3%-0.049-3%
Return On Equity---0.057-0.081+42%-0.165+189%-0.074+29%-0.074+29%
Total Gains Per Share---0.0300.486-106%-0.325+976%0.274-111%0.274-111%
Usd Book Value--160362000.000156009500.000+3%104752500.000+53%26209812.500+512%26209812.500+512%
Usd Book Value Change Per Share---0.0300.476-106%-0.327+982%0.271-111%0.271-111%
Usd Book Value Per Share--4.3364.218+3%2.832+53%0.709+512%0.709+512%
Usd Dividend Per Share---0.010-100%0.002-100%0.003-100%0.003-100%
Usd Eps---0.248-0.329+32%-0.451+82%-0.287+15%-0.287+15%
Usd Free Cash Flow---11480000.000-11998750.000+5%-15310750.000+33%-12101750.000+5%-12101750.000+5%
Usd Free Cash Flow Per Share---0.310-0.324+5%-0.414+33%-0.327+5%-0.327+5%
Usd Free Cash Flow To Equity Per Share---0.1710.102-267%-0.371+117%0.065-364%0.065-364%
Usd Market Cap1874161692.000+20%1491340032.0001051280061.000+42%472793997.000+215%436314976.500+242%436314976.500+242%
Usd Price Per Share50.670+20%40.32028.423+42%12.783+215%11.796+242%11.796+242%
Usd Profit---9177000.000-12557500.000+37%-17139000.000+87%-8743750.000-5%-8743750.000-5%
Usd Revenue--28580000.00024386500.000+17%12251250.000+133%11488937.500+149%11488937.500+149%
Usd Total Gains Per Share---0.0300.486-106%-0.325+976%0.274-111%0.274-111%
 EOD+5 -3MRQTTM+22 -13YOY+28 -75Y+20 -1510Y+20 -15

4.2. Fundamental Score

Let's check the fundamental score of Rxsight Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-51.056
Price to Book Ratio (EOD)Between0-111.687
Net Profit Margin (MRQ)Greater than0-0.321
Operating Margin (MRQ)Greater than0-0.380
Quick Ratio (MRQ)Greater than112.675
Current Ratio (MRQ)Greater than18.057
Debt to Asset Ratio (MRQ)Less than10.122
Debt to Equity Ratio (MRQ)Less than10.138
Return on Equity (MRQ)Greater than0.15-0.057
Return on Assets (MRQ)Greater than0.05-0.050
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Rxsight Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5051.146
Ma 20Greater thanMa 5050.854
Ma 50Greater thanMa 10050.427
Ma 100Greater thanMa 20042.274
OpenGreater thanClose49.770
Total4/5 (80.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Income Tax Expense  51,6171,622-1,59626-1412-30-18



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets182,550
Total Liabilities22,188
Total Stockholder Equity160,362
 As reported
Total Liabilities 22,188
Total Stockholder Equity+ 160,362
Total Assets = 182,550

Assets

Total Assets182,550
Total Current Assets168,407
Long-term Assets14,143
Total Current Assets
Cash And Cash Equivalents 9,692
Short-term Investments 117,490
Net Receivables 20,281
Inventory 17,421
Other Current Assets 3,523
Total Current Assets  (as reported)168,407
Total Current Assets  (calculated)168,407
+/-0
Long-term Assets
Property Plant Equipment 13,285
Long-term Assets Other 147
Long-term Assets  (as reported)14,143
Long-term Assets  (calculated)13,432
+/- 711

Liabilities & Shareholders' Equity

Total Current Liabilities20,903
Long-term Liabilities1,285
Total Stockholder Equity160,362
Total Current Liabilities
Short-term Debt 1,801
Accounts payable 3,863
Other Current Liabilities 13,194
Total Current Liabilities  (as reported)20,903
Total Current Liabilities  (calculated)18,858
+/- 2,045
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt1,211
Long-term Liabilities Other 74
Long-term Liabilities  (as reported)1,285
Long-term Liabilities  (calculated)1,285
+/-0
Total Stockholder Equity
Common Stock36
Retained Earnings -594,640
Accumulated Other Comprehensive Income -5
Other Stockholders Equity 754,971
Total Stockholder Equity (as reported)160,362
Total Stockholder Equity (calculated)160,362
+/-0
Other
Capital Stock36
Cash and Short Term Investments 127,182
Common Stock Shares Outstanding 35,962
Current Deferred Revenue2,045
Liabilities and Stockholders Equity 182,550
Net Debt -6,680
Net Invested Capital 160,362
Net Working Capital 147,504
Property Plant and Equipment Gross 35,983
Short Long Term Debt Total 3,012



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-31
> Total Assets 
0
0
0
100,677
96,291
94,886
203,736
192,721
177,062
166,714
155,706
150,164
202,532
195,261
181,850
182,550
182,550181,850195,261202,532150,164155,706166,714177,062192,721203,73694,88696,291100,677000
   > Total Current Assets 
0
0
0
81,500
77,844
75,546
186,336
176,295
161,147
149,928
139,162
134,555
187,666
180,445
167,947
168,407
168,407167,947180,445187,666134,555139,162149,928161,147176,295186,33675,54677,84481,500000
       Cash And Cash Equivalents 
0
0
0
13,994
24,385
41,731
68,278
24,361
24,132
24,004
8,912
11,834
11,012
8,753
9,859
9,692
9,6929,8598,75311,01211,8348,91224,00424,13224,36168,27841,73124,38513,994000
       Short-term Investments 
0
0
0
54,981
39,997
19,998
99,985
134,971
119,715
104,616
103,923
93,968
142,927
138,340
122,023
117,490
117,490122,023138,340142,92793,968103,923104,616119,715134,97199,98519,99839,99754,981000
       Net Receivables 
0
0
0
2,865
2,266
3,936
4,357
4,862
5,626
6,884
9,020
10,956
12,668
13,295
15,244
20,281
20,28115,24413,29512,66810,9569,0206,8845,6264,8624,3573,9362,2662,865000
       Other Current Assets 
0
0
0
1,372
1,436
1,338
4,274
4,069
3,184
2,802
1,971
2,962
2,992
2,112
1,897
3,523
3,5231,8972,1122,9922,9621,9712,8023,1844,0694,2741,3381,4361,372000
   > Long-term Assets 
0
0
0
19,177
18,447
19,340
17,400
16,426
15,915
16,786
16,544
15,609
14,866
14,816
13,903
14,143
14,14313,90314,81614,86615,60916,54416,78615,91516,42617,40019,34018,44719,177000
       Property Plant Equipment 
0
0
0
18,606
17,876
17,435
16,552
15,501
14,972
15,787
14,951
14,081
13,359
13,707
13,055
13,285
13,28513,05513,70713,35914,08114,95115,78714,97215,50116,55217,43517,87618,606000
       Other Assets 
0
0
0
0
571
1,905
848
925
943
999
1,593
1,528
0
1,109
0
0
001,10901,5281,5939999439258481,9055710000
> Total Liabilities 
0
0
0
398,206
398,190
408,282
52,845
54,479
53,899
56,728
59,747
60,262
57,523
38,073
20,371
22,188
22,18820,37138,07357,52360,26259,74756,72853,89954,47952,845408,282398,190398,206000
   > Total Current Liabilities 
0
0
0
11,600
6,857
11,102
9,176
11,077
10,659
12,996
16,368
17,237
14,876
16,565
18,942
20,903
20,90318,94216,56514,87617,23716,36812,99610,65911,0779,17611,1026,85711,600000
       Short-term Debt 
0
0
0
1,274
1,317
1,365
1,469
1,529
1,663
1,842
1,948
1,970
1,978
1,980
1,976
1,801
1,8011,9761,9801,9781,9701,9481,8421,6631,5291,4691,3651,3171,274000
       Accounts payable 
0
0
0
1,134
1,861
2,342
1,691
1,689
2,587
3,277
4,172
2,595
3,717
3,997
4,105
3,863
3,8634,1053,9973,7172,5954,1723,2772,5871,6891,6912,3421,8611,134000
       Other Current Liabilities 
0
0
0
8,754
3,679
2,614
6,016
7,241
6,409
7,877
10,248
11,324
9,181
10,588
12,861
13,194
13,19412,86110,5889,18111,32410,2487,8776,4097,2416,0162,6143,6798,754000
   > Long-term Liabilities 
0
0
0
386,606
391,333
397,180
43,669
43,402
43,240
43,732
43,379
43,025
42,647
21,508
1,429
1,285
1,2851,42921,50842,64743,02543,37943,73243,24043,40243,669397,180391,333386,606000
       Long term Debt Total 
0
0
0
0
0
43,880
43,669
43,402
43,240
43,732
43,379
0
42,647
0
0
0
00042,647043,37943,73243,24043,40243,66943,88000000
       Warrants
0
0
0
0
0
353,300
0
0
0
0
0
0
0
0
0
0
0000000000353,30000000
       Other Liabilities 
0
0
0
0
3,828
0
0
0
0
0
0
0
0
76
0
0
0076000000003,8280000
> Total Stockholder Equity
0
0
0
-297,529
-301,899
-313,396
150,891
138,242
123,163
109,986
95,959
89,902
145,009
157,188
161,479
160,362
160,362161,479157,188145,00989,90295,959109,986123,163138,242150,891-313,396-301,899-297,529000
   Common Stock
0
0
0
80,780
4
4
27
27
27
27
28
28
34
35
36
36
363635342828272727274480,780000
   Retained Earnings Total Equity000-559,244-546,032-530,422-513,604-496,872-479,276-463,543-450,87000000
   Accumulated Other Comprehensive Income -5-60-73-9-95-138-183-98-20-11-30-3000
   Capital Surplus 
0
0
0
0
0
137,838
614,418
617,511
620,106
623,746
626,491
636,001
704,228
0
0
0
000704,228636,001626,491623,746620,106617,511614,418137,83800000
   Treasury Stock0000000000000000
   Other Stockholders Equity 
0
0
0
52,282
135,490
-215,827
410,682
617,511
620,106
623,746
626,491
636,001
704,228
730,274
746,966
754,971
754,971746,966730,274704,228636,001626,491623,746620,106617,511410,682-215,827135,49052,282000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue89,077
Cost of Revenue-35,312
Gross Profit53,76553,765
 
Operating Income (+$)
Gross Profit53,765
Operating Expense-103,850
Operating Income-50,085-50,085
 
Operating Expense (+$)
Research Development29,051
Selling General Administrative74,799
Selling And Marketing Expenses0
Operating Expense103,850103,850
 
Net Interest Income (+$)
Interest Income6,574
Interest Expense-3,308
Other Finance Cost-0
Net Interest Income3,266
 
Pretax Income (+$)
Operating Income-50,085
Net Interest Income3,266
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-48,588-51,582
EBIT - interestExpense = -53,393
-48,588
-45,300
Interest Expense3,308
Earnings Before Interest and Taxes (EBIT)-50,085-45,280
Earnings Before Interest and Taxes (EBITDA)-45,842
 
After tax Income (+$)
Income Before Tax-48,588
Tax Provision-20
Net Income From Continuing Ops-48,608-48,608
Net Income-48,608
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses139,162
Total Other Income/Expenses Net1,497-3,266
 

Technical Analysis of Rxsight
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Rxsight. The general trend of Rxsight is BULLISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Rxsight's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (71.4%) Bearish trend (-71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Rxsight Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 58.21.

The bearish price targets are: 45.48 > 45.23 > 43.55.

Tweet this
Rxsight Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Rxsight Inc. The current mas is .

The long score for the Moving Averages is 12/14.
The longshort score for the Moving Averages is 10/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Rxsight Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Rxsight Inc. The current macd is -0.55246035.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Rxsight price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Rxsight. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Rxsight price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Rxsight Inc Daily Moving Average Convergence/Divergence (MACD) ChartRxsight Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Rxsight Inc. The current adx is 21.47.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Rxsight shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Rxsight Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Rxsight Inc. The current sar is 46.07.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Rxsight Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Rxsight Inc. The current rsi is 51.15. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
Rxsight Inc Daily Relative Strength Index (RSI) ChartRxsight Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Rxsight Inc. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Rxsight price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Rxsight Inc Daily Stochastic Oscillator ChartRxsight Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Rxsight Inc. The current cci is -20.2863905.

Rxsight Inc Daily Commodity Channel Index (CCI) ChartRxsight Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Rxsight Inc. The current cmo is 5.56590324.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Rxsight Inc Daily Chande Momentum Oscillator (CMO) ChartRxsight Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Rxsight Inc. The current willr is -43.77260982.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Rxsight is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Rxsight Inc Daily Williams %R ChartRxsight Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Rxsight Inc.

Rxsight Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Rxsight Inc. The current atr is 2.44259323.

Rxsight Inc Daily Average True Range (ATR) ChartRxsight Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Rxsight Inc. The current obv is 18,822,957.

Rxsight Inc Daily On-Balance Volume (OBV) ChartRxsight Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Rxsight Inc. The current mfi is 31.63.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Rxsight Inc Daily Money Flow Index (MFI) ChartRxsight Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Rxsight Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-07WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-09DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-10DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-13STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-14BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-11-16STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-20STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-21STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-22STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-28STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-30STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-01SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-04SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-05BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-06STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-07STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-08BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-11STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-12STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-13STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-15MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-26STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-02SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-03WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-08SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-16RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-19RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-23RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-01-24MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-29STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-02STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-08STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-09BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-02-12WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-13SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-02-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-23RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-28RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-06SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-11CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-14ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside

6.3. Candlestick Patterns

Rxsight Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Rxsight Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5051.146
Ma 20Greater thanMa 5050.854
Ma 50Greater thanMa 10050.427
Ma 100Greater thanMa 20042.274
OpenGreater thanClose49.770
Total4/5 (80.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Rxsight with someone you think should read this too:
  • Are you bullish or bearish on Rxsight? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Rxsight? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Rxsight Inc

I send you an email if I find something interesting about Rxsight Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Rxsight Inc.

Receive notifications about Rxsight Inc in your mailbox!